U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,125.00
+25.00 (0.81%)
At close: Aug 14, 2025, 3:30 PM KST

U2Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2014 FY 2013
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '14 Dec '13
Market Capitalization
35,27230,08059,59649,318--
Market Cap Growth
-22.01%-49.53%20.84%---
Enterprise Value
1,407-3,86623,19752,691--
Last Close Price
3125.002665.005280.006451.26--
PE Ratio
--92.273.75--
PS Ratio
1.411.201.940.72--
PB Ratio
1.030.871.571.46--
P/TBV Ratio
1.070.881.581.47--
P/FCF Ratio
---2.10--
P/OCF Ratio
---2.02--
EV/Sales Ratio
0.06-0.750.76--
EV/EBITDA Ratio
---3.18--
EV/EBIT Ratio
---3.35--
EV/FCF Ratio
-2.07--2.25--
Debt / Equity Ratio
0.010.010.010.021.132.31
Debt / EBITDA Ratio
---0.034.775.73
Debt / FCF Ratio
---0.02--
Asset Turnover
0.550.530.61-1.06-
Inventory Turnover
25.5226.4930.54-18.23-
Quick Ratio
6.686.275.523.221.791.51
Current Ratio
6.876.405.643.271.881.64
Return on Equity (ROE)
-7.70%-7.85%1.80%-9.93%-
Return on Assets (ROA)
-3.81%-3.89%-1.67%-4.15%-
Return on Capital (ROIC)
-4.84%-4.99%-2.30%-6.34%-
Return on Capital Employed (ROCE)
---43.20%11.10%11.90%
Earnings Yield
-7.79%-9.44%1.08%26.68%--
FCF Yield
-1.93%-5.90%-4.65%47.53%--
Payout Ratio
--195.50%5.76%--
Buyback Yield / Dilution
-6.54%-10.09%-1.51%-598.90%-22.57%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.